Business Wire

DOTMATICS

Share
Dotmatics Announces Vortex for Bioinformatics

Dotmatics , a leading provider of scientific informatics solutions and services, today announced Vortex for Bioinformatics , an easy-to-use program designed to allow all bioscientists to analyse and visualise their data to make better-informed decisions.

Built into the long established and widely used Vortex program, Vortex for Bioinformatics can handle whole genome, antibody, protein and peptide data types and can scale to handle massive amounts of data including whole genomes on a laptop. With novel methods to relate biologic structure and sequence to activity, Vortex for Bioinformatics helps users understand assay results and drive forward the design of biologics with high performance analysis and visualization.

“Traditionally, a small number of experts are required to perform the analysis and visualization of bioinformatics data,” said Mike Hartshorn, PhD, Dotmatics Chief Science Officer. “These are the individuals who can script together the algorithms and programs needed to complete the discovery of knowledge. With Vortex for Bioinformatics, Dotmatics is broadening access to critical scientific methods while enabling discovery at the bench.”

Once a user loads bioinformatics data from files or directly from databases, Vortex for Bioinformatics displays the live sequences in a variety of formats. A selection of analysis algorithms is available including alignment, cross-alignment, clustering and search. The software makes intelligent selections of the correct methods to use based on the number and type of the sequences being analysed. This ensures that users can obtain appropriate results without having to know all of the algorithmic details, while power users can make manual selections. Expert bioinformatics can integrate additional methods via scripting

When used in conjunction with Dotmatics 5.0 informatics applications such as BioELN and BioReg , Vortex can seamlessly become an integral part of the biologics discovery workflow.

To learn more about Vortex for Bioinformatics and why Vortex has been successful throughout the pharma and biotech industry for cheminformatics, statistical analysis and visualization with 1000s of users across 100s of companies, please contact Dotmatics , view the webinar or video .

About Dotmatics:

Dotmatics is a leading global scientific informatics software and services provider, delivering solutions tailored to the modern, highly collaborative and mobile scientific environments. The company provides solutions to several vertical markets, including the pharmaceutical, biotechnology, academia, food and beverage, oil and gas and agrochemical industries. Dotmatics’ enterprise solutions are flexible, scalable and configurable, providing effective scientific information management across entire organisations, from discovery research to development and early manufacturing. Dotmatics has significant expertise in scientific informatics, including database management for chemistry and biologics, electronic laboratory notebooks, chemical and biological registration, screening data management, SAR analysis, reporting, and visualisation. Dotmatics solutions are available for local or cloud deployment and supported on Microsoft Windows, Mac OS X and Linux. For more information visit dotmatics.com .

Contact:

Media:
Marla Kertzman, 209-852-9027
pr@dotmatics.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AB InBev Reports First Quarter 2025 Results8.5.2025 07:03:00 CEST | Press release

Solid start to the year with EBITDA growth at the top-end of our outlook, continued margin expansion and high-single digit Underlying EPS growth Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507671244/en/ AB InBev Strategic Priorities Regulated information1 “Beer is a passion point for consumers. The strength of the beer category and the continued momentum of our megabrands delivered another quarter of profitable growth. EBITDA increased at the top-end of our outlook and the ongoing optimization of our business drove Underlying EPS growth of 7.1%. The consistent execution of our strategy by our teams and partners drove a solid start to the year and reinforces our confidence in delivering on our outlook for 2025.” – Michel Doukeris, CEO, AB InBev Revenue +1.5% Revenue increased by 1.5% with revenue per hl growth of 3.7%. Reported revenue decreased by 6.3%

Rimini Street and ServiceNow Partner with Apsen Farmacêutica to Deliver a Next-Generation Vision of Enterprise-Wide Workflow Automation7.5.2025 18:55:00 CEST | Press release

Pharmaceutical manufacturer layers ServiceNow over its existing SAP ECC 6 ERP platform, enables intelligent workflow and automation for immediate business impact and avoids low ROI spend on expensive, risky vendor-mandated migration to SAP S/4HANA Knowledge 2025 —Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, management and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today at ServiceNow’s annual customer and partner event, Knowledge 2025, announced that Apsen Farmacêutica, a Brazilian pharmaceutical manufacturer, has partnered with Rimini Street and ServiceNow to implement a next-generation vision of enterprise-wide workflow automation. This new vision will enable autonomy across the company to help respond faster to market changes, reduce information silos and improve operational efficiency. This press release features multimedia. View the full release here: https://www.busine

Results from the VirTus Respiratory Research Ltd Human Rhinovirus Challenge Model Used to Advance Altesa BioSciences’ Lead Medicine into Advanced Clinical Trials7.5.2025 18:07:00 CEST | Press release

Study conducted by VirTus Respiratory Research demonstrated that vapendavir has potent antiviral activity and improves symptoms in participants with COPD infected with rhinovirus VirTus Respiratory Research Ltd, a leading respiratory-focused contract research organisation (CRO), today announced that results from their human rhinovirus challenge model in patients with chronic obstructive pulmonary disease (COPD) provided Altesa BioSciences with compelling evidence to advance their lead drug candidate, vapendavir, into large scale, late-stage clinical trials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507489716/en/ Professor Sebastian Johnston https://www.prnewswire.com/news-releases/altesa-biosciences-details-positive-topline-vapendavir-results-from-phase-2-placebo-controlled-rhinovirus-challenge-study-in-copd-patients-302448650.html Rhinovirus infection is the cause of at least half of the acute respiratory deteriorat

FlightSafety International Announces Major Expansion at Farnborough Airport7.5.2025 17:56:00 CEST | Press release

FlightSafety International (FSI), a global leader in aviation training, is pleased to announce the expansion of its facilities at Farnborough Airport, the home of British aviation and Europe’s leading airport for premium air travel connectivity, highlighting its commitment to enhancing aviation safety and training excellence in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250506583636/en/ Rendering: arriving at FlightSafety International The new FSI centre is expected to open in the second quarter of 2027. Lease terms have been finalised and the planning application was submitted in January. Construction is scheduled to start in late 2025 and finish by early 2027. FSI has operated a training centre at Farnborough Airport since 2004. The new facilities will boost training capacity by 40-50%, enabling more aviation professionals access to FSI's world-class training programmes. The current facility is 4,680 square met

Verimatrix Positioned as a Leader and Ace Performer in the 2025 SPARK MatrixTM for In-App Protection by QKS Group7.5.2025 17:45:00 CEST | Press release

The QKS Group SPARK Matrix™ provides competitive analysis and ranking of the leading In-App Protection vendors.Verimatrix is recognized for its comprehensive in-app protection capabilities, earning strong ratings across both Technology Excellence and Customer Impact in the latest SPARK Matrix™.Verimatrix has also been named an Ace Performer – a recognition given to vendors that demonstrate revenue growth potential, partnership strategy, and customer acquisition – all evaluated over the last one-year period or since the previous SPARK Matrix™ assessment. Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507970501/en/ Verimatrix positioned as a Leader in the 2025 SPARK Matrix™ for In-App Protection by QKS Group. Verimatrix has been recognized for its comprehensive in-app protection capabilities, earning strong ratings across both Technology Excellence and Customer Impact in the latest SPARK Matrix™. The compan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye